Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy. [electronic resource]
Producer: 20170516Description: 432-9 p. digitalISSN:- 1423-0194
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine -- therapeutic use
- Dacarbazine -- analogs & derivatives
- Female
- Humans
- Kaplan-Meier Estimate
- Longitudinal Studies
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neuroendocrine Tumors -- diagnostic imaging
- Octreotide -- analogs & derivatives
- Pancreatic Neoplasms -- diagnostic imaging
- Temozolomide
- Tomography Scanners, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.